Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Obstructive Lung Diseases

Free Subscription Articles published in Arch Bronconeumol Retrieve available abstracts of 172 articles: HTML format

Single Articles

April 2024
1. MAKRINIOTI H, Zhu Z, Saglani S, Camargo CA, et al
   Infant Bronchiolitis Endotypes and the Risk of Developing Childhood Asthma: Lessons From Cohort Studies.
   Arch Bronconeumol. 2024;60:215-225.
   PubMed     Abstract available
   
   
   
2. DE MIGUEL-DIEZ J, Nunez Villota J, Santos Perez S, Manito Lorite N, et al
   Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
   Arch Bronconeumol. 2024;60:226-237.
   PubMed     Abstract available
   
   
   March 2024
3. GAO YH, Zhu YN, Bai JW, Liang S, et al
   Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
   Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
   PubMed    
   
   
   
4. CHANG AB, Dharmage SC, Marchant JM, McCallum GB, et al
   Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation.
   Arch Bronconeumol. 2024 Mar 10:S0300-2896(24)00062.
   PubMed     Abstract available
   
   
   
5. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
   Effect of Comorbidities and Gender Differences in Survival in Patients With Bronchiectasis.
   Arch Bronconeumol. 2024 Mar 2:S0300-2896(24)00055.
   PubMed    
   
   
   
6. VITACCA M, Malovini A, Paneroni M, Spanevello A, et al
   Predicting Response to In-Hospital Pulmonary Rehabilitation in Individuals Recovering From Exacerbations of Chronic Obstructive Pulmonary Disease.
   Arch Bronconeumol. 2024;60:153-160.
   PubMed     Abstract available
   
   
   February 2024
7. FAIZ A, Wiersma VR, Salzbrunn JB, Brandsma CA, et al
   COPD Patients Display Increased Peripheral Blood Somatic Mutations Which Associate With the Prevalence of Co-morbidities.
   Arch Bronconeumol. 2024;60:119-121.
   PubMed    
   
   
   
8. GIRON MATUTE WI, Ji Z, de Miguel Diez J
   Clinical Trials in COPD: Future Challenges.
   Arch Bronconeumol. 2024;60:75-76.
   PubMed    
   
   
   January 2024
9. PALONES E, Garcia-Rivero JL, Cisneros C, Almonacid-Sanchez C, et al
   Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma.
   Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00003.
   PubMed    
   
   
   
10. MAKRINIOTI H, Homil K, Hurme P, Erkkola R, et al
    Peripheral Blood MxA Levels During a First Acute Wheezing Episode and the Link to Childhood Asthma.
    Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00001.
    PubMed    
    
    
    
11. BEASLEY R, Ferreira DS, Papi A
    As-needed Dual Inhaled Corticosteroid-Formoterol in Mild Asthma: Scientific Evidence.
    Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00004.
    PubMed    
    
    
    
12. LI W, Dong P, Wang W
    Unveiling the Link between Asthma and Cancer Risk: Shedding New Light through Mendelian Randomization.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00418.
    PubMed    
    
    
    
13. LUNA-PARDO C, Cruz-Chamorro DA, Martinez-Tomas R, Briones-Gomez A, et al
    Endoscopic Lung Volume Reduction With Vapor Ablation in Patients With Severe Emphysema.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00419.
    PubMed    
    
    
    
14. DE-TORRES JP, Alcaide AB, Campo A, Zulueta JJ, et al
    Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00417.
    PubMed     Abstract available
    
    
    
15. LOEB E, Zock JP, Miravitlles M, Rodriguez E, et al
    Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population.
    Arch Bronconeumol. 2024;60:16-22.
    PubMed     Abstract available
    
    
    
16. FIGUEIRA-GONCALVES JM, de Miguel-Diez J
    Initial Treatment in COPD Patients. Do We Take into Account the Severity of the Exacerbation?
    Arch Bronconeumol. 2024;60:65-66.
    PubMed    
    
    
    
17. RIESCO MIRANDA JA, Calle Rubio M, Diaz Perez D, Lopez-Campos JL, et al
    Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review.
    Arch Bronconeumol. 2024;60:55-58.
    PubMed    
    
    
    
18. DE-TORRES JP, Casanova C, Marin JM, Cabrera C, et al
    Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience.
    Arch Bronconeumol. 2024;60:10-15.
    PubMed     Abstract available
    
    
    
19. DE MIGUEL-DIEZ J, Figueira-Goncalves JM, Trillo-Calvo E, Cimas-Hernando JE, et al
    Referral Criteria for Chronic Obstructive Pulmonary Disease: A Proposal of Continuity of Care.
    Arch Bronconeumol. 2024;60:7-9.
    PubMed    
    
    
    December 2023
20. ORDONEZ LOZANO PA, Ruiz JM, Rey Gutama H
    Large Cystic Bronchiectasis: A Differential Diagnosis.
    Arch Bronconeumol. 2023 Dec 18:S0300-2896(23)00408.
    PubMed    
    
    
    
21. MORENA D, Lumbreras S, Rodriguez JM, Campos C, et al
    Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection.
    Arch Bronconeumol. 2023;59:797-804.
    PubMed     Abstract available
    
    
    
22. BUSTAMANTE-GUEVARA GV, Iglesias-Serrano I, Camacho Soriano J
    Refractory Inflammatory Plastic Bronchitis in Children and the Use of Mepolizumab as a Treatment.
    Arch Bronconeumol. 2023;59:829-830.
    PubMed    
    
    
    November 2023
23. VALVERDE-MONGE M, Sanchez-Carrasco P, Betancor D, Barroso B, et al
    Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients.
    Arch Bronconeumol. 2023 Nov 22:S0300-2896(23)00379.
    PubMed     Abstract available
    
    
    
24. CALLE RUBIO M, Miravitlles M, Lopez-Campos JL, Alcazar Navarrete B, et al
    Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit.
    Arch Bronconeumol. 2023;59:725-735.
    PubMed     Abstract available
    
    
    
25. REY-BRANDARIZ J, Perez-Rios M, Ahluwalia JS, Beheshtian K, et al
    Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study.
    Arch Bronconeumol. 2023;59:717-724.
    PubMed     Abstract available
    
    
    
26. MARTINEZ TOMAS R, Briones-Gomez A, Cases Viedma E
    Bronchoscopy Valves for Lung Volume Reduction: Present and Future.
    Arch Bronconeumol. 2023;59:707-708.
    PubMed    
    
    
    October 2023
27. ALMONACID-SANCHEZ C, Garcia-Cosio B, Trisan-Alonso A, Callejas-Gonzalez FJ, et al
    Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population.
    Arch Bronconeumol. 2023 Oct 5:S0300-2896(23)00310.
    PubMed    
    
    
    September 2023
28. COHEN D, Osadchy A, Cohen-Hagai K, Jarchowsky Dolberg O, et al
    Bronchiectasis in Subjects With Chronic Lymphocytic Leukemia.
    Arch Bronconeumol. 2023 Sep 29:S0300-2896(23)00308.
    PubMed    
    
    
    
29. DE DIEGO DAMIA A, Martinez Valle AM
    Antialarmins in Severe Asthma.
    Arch Bronconeumol. 2023 Sep 29:S0300-2896(23)00303.
    PubMed    
    
    
    
30. RABOSO MORENO B, Calero Pardo S, Abad Fernandez A
    Bardet-Biedl Syndrome: An Uncommon Cause of Bronchiectasis.
    Arch Bronconeumol. 2023 Sep 9:S0300-2896(23)00281.
    PubMed    
    
    
    
31. AUSIN P, Navarrete-Rouco ME
    Multiple Targets, Multiple Pathways, Multiple Strategies in the Treatment of Asthma.
    Arch Bronconeumol. 2023 Sep 6:S0300-2896(23)00279.
    PubMed    
    
    
    August 2023
32. PINOT DE MOIRA A, Taylor-Robinson D
    Social Inequalities in Asthma: The Cold Facts.
    Arch Bronconeumol. 2023 Aug 5:S0300-2896(23)00263.
    PubMed    
    
    
    
33. PILIA MF, Cruz MJ, Ma D, Romero-Mesones C, et al
    The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy.
    Arch Bronconeumol. 2023 Aug 5:S0300-2896(23)00264.
    PubMed     Abstract available
    
    
    
34. DELORME M, Leotard A, Lebret M, Lefeuvre C, et al
    Effect of Intensity of Home Noninvasive Ventilation in Individuals With Neuromuscular and Chest Wall Disorders: A Systematic Review and Meta-Analysis of Individual Participant Data.
    Arch Bronconeumol. 2023;59:488-496.
    PubMed     Abstract available
    
    
    July 2023
35. MARTINEZ-GARCIA MA, Oscullo G, Gomez-Olivas JD, Olveira C, et al
    Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries.
    Arch Bronconeumol. 2023 Jul 27:S0300-2896(23)00261.
    PubMed    
    
    
    
36. CAZZOLA M, Matera MG, Martinez-Garcia MA
    Dual Broncodilator and Triple Therapy in Bronchiectasis. Clinical Trials are Urgently Needed.
    Arch Bronconeumol. 2023 Jul 22:S0300-2896(23)00228.
    PubMed    
    
    
    
37. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
    Impact of Comorbidities in Clinical Outcomes in Patients Admitted for Exacerbation of Bronchiectasis.
    Arch Bronconeumol. 2023 Jul 22:S0300-2896(23)00234.
    PubMed    
    
    
    
38. DE LA ROSA-CARRILLO D, Maiz-Carro L, Martinez-Garcia MA
    What Have We Learned About Bronchiectasis From RIBRON (Spanish Bronchiectasis Registry)?
    Arch Bronconeumol. 2023 Jul 15:S0300-2896(23)00226.
    PubMed    
    
    
    
39. SALAHUDDIN M, Alavi M, Nasir S
    Invasive Aspergillosis and Pseudomembranous Tracheitis in Uncontrolled Diabetes.
    Arch Bronconeumol. 2023;59:449-450.
    PubMed    
    
    
    
40. BLANCO I, Diego I, Castanon C, Bueno P, et al
    Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:427-434.
    PubMed     Abstract available
    
    
    
41. FIGUEIRA-GONCALVES JM, Golpe R
    Impact of Oral Antidiabetics Agents in the Prevention of COPD Exacerbations.
    Arch Bronconeumol. 2023;59:412-413.
    PubMed    
    
    
    June 2023
42. FIGUEIRA-GONCALVES JM, Hernandez-Perez JM, Cabrera-Lopez C, Wanguemert-Perez AL, et al
    Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease.
    Arch Bronconeumol. 2023;59:403-405.
    PubMed    
    
    
    
43. RODRIGUEZ-SEGADE ALONSO S, Diego Roza C, Marzoa Rivas R, Nieto Codesido I, et al
    Prevalence and Risk Factors for Airflow Limitation in Patients With Acute Coronary Syndrome.
    Arch Bronconeumol. 2023;59:397-400.
    PubMed    
    
    
    
44. LACASSE Y, Maltais F
    When and When Not to Prescribe Home Oxygen in COPD.
    Arch Bronconeumol. 2023;59:350-351.
    PubMed    
    
    
    
45. BETANCOR D, Villalobos-Vilda C, Olaguibel JM, Rodrigo-Munoz JM, et al
    The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort.
    Arch Bronconeumol. 2023 Jun 1:S0300-2896(23)00173.
    PubMed    
    
    
    
46. COSIO BG, Shafiek H, Iglesias A, Mosteiro M, et al
    Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils.
    Arch Bronconeumol. 2023 Jun 1:S0300-2896(23)00172.
    PubMed     Abstract available
    
    
    May 2023
47. GONZALEZ-DE PAZ L, Valdesoiro-Navarrete L, Roma J, Blat-Guimera E, et al
    Prevalence and Impact of Asthma and Allergy on Daily Life, Health Outcomes and Use of Healthcare Services in Children: A Population-Based Study.
    Arch Bronconeumol. 2023 May 24:S0300-2896(23)00163.
    PubMed     Abstract available
    
    
    
48. MARTINEZ RIVERA C, Serra Mitja P, Andreo Garcia F, Crespo-Lessmann A, et al
    Factors Associated With Large Airway Collapse in Severe Asthma.
    Arch Bronconeumol. 2023 May 24:S0300-2896(23)00164.
    PubMed    
    
    
    
49. MARTINEZ-MORAGON E
    Cost-Effectiveness of Biologic Therapies in Asthma in Spain.
    Arch Bronconeumol. 2023 May 23:S0300-2896(23)00165.
    PubMed    
    
    
    
50. CALLE RUBIO M, Lopez-Campos JL, Miravitlles M, Soler Cataluna JJ, et al
    Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit.
    Arch Bronconeumol. 2023;59:295-304.
    PubMed     Abstract available
    
    
    
51. GEA J, Enriquez-Rodriguez CJ, Pascual-Guardia S
    Metabolomics in COPD.
    Arch Bronconeumol. 2023;59:311-321.
    PubMed     Abstract available
    
    
    
52. POLVERINO F, Celli B
    Challenges in the Pharmacotherapy of COPD Subtypes.
    Arch Bronconeumol. 2023;59:284-287.
    PubMed    
    
    
    April 2023
53. JIMENEZ-GOMEZ M, Diaz Campos RM, Diab Caceres L
    Cystic Fibrosis-Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma.
    Arch Bronconeumol. 2023 Apr 20:S0300-2896(23)00126.
    PubMed    
    
    
    
54. GALAN-NEGRILLO M, Garcia-Pachon E
    Reduction in Hospital Admissions for Asthma and COPD During the First Year of COVID-19 Pandemic in Spain.
    Arch Bronconeumol. 2023 Apr 20:S0300-2896(23)00125.
    PubMed    
    
    
    
55. AGUSTI A, Celli BR, Criner GJ, Halpin D, et al
    Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
    Arch Bronconeumol. 2023;59:232-248.
    PubMed    
    
    
    
56. GONZALEZ J, de Batlle J, Benitez ID, Torres G, et al
    Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
    Arch Bronconeumol. 2023;59:205-215.
    PubMed     Abstract available
    
    
    
57. MARQUEZ CABALLERO J, Cordero Matia ME
    Epidemiology of Acute Bronchiolitis in a Third-level Hospital During the COVID-19 Pandemic.
    Arch Bronconeumol. 2023;59:264-266.
    PubMed    
    
    
    March 2023
58. PEREZ-DE-LLANO L, Veiga-Teijeiro I, Dacal-Rivas D
    Contribution of the Remission Concept to the Treatment of Asthma.
    Arch Bronconeumol. 2023 Mar 21:S0300-2896(23)00108.
    PubMed    
    
    
    
59. LOBO-REBOLLO MJ, Garcia-Baron C, Villar-Alvarez F
    Acute Hemorrhage into an Emphysematous Bulla.
    Arch Bronconeumol. 2023 Mar 21:S0300-2896(23)00106.
    PubMed    
    
    
    
60. GARCIA CASTILLO E, Alonso Perez T, Pelaez A, Perez Gonzalez P, et al
    Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017.
    Arch Bronconeumol. 2023;59:142-151.
    PubMed     Abstract available
    
    
    
61. PEREIRA BARROS P, Dos Santos B, Brito U
    Difficult Diagnosis of a Foreign Body Inhalation in a COPD Patient.
    Arch Bronconeumol. 2023;59:172.
    PubMed    
    
    
    
62. MAESTRI R, Vitacca M, Paneroni M, Zampogna E, et al
    Gender and Age as Determinants of Success of Pulmonary Rehabilitation in Individuals With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:174-177.
    PubMed    
    
    
    February 2023
63. HERNANDEZ-PEREZ JM, Martin-Gonzalez E, Gonzalez-Carracedo MA
    Alpha-1 Antitrypsin Deficiency and SERPINA1 Variants Could Play a Role in Asthma Exacerbations.
    Arch Bronconeumol. 2023 Feb 28:S0300-2896(23)00038.
    PubMed    
    
    
    
64. ARISMENDI E, Bantula M, Picado C
    Obese Asthma Syndrome: Much Work to Do.
    Arch Bronconeumol. 2023 Feb 25:S0300-2896(23)00040.
    PubMed    
    
    
    
65. ALCARAZ-SERRANO V, Sanz-Fraile H, Bueno-Freire L, Farre R, et al
    Association Between Viscoelastic Characteristics and Sputum Colour in Patients With Bronchiectasis.
    Arch Bronconeumol. 2023 Feb 25:S0300-2896(23)00039.
    PubMed    
    
    
    
66. PASCUAL-GUARDIA S, Amati F, Marin-Corral J, Aliberti S, et al
    Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia.
    Arch Bronconeumol. 2023;59:90-100.
    PubMed     Abstract available
    
    
    
67. LOPEZ-CAMPOS JL, Caballero Eraso C
    Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: So Far, So Good.
    Arch Bronconeumol. 2023;59:71-72.
    PubMed    
    
    
    
68. LOPEZ-PARDO ME, Candal-Pedreira C, Valdes-Cuadrado L, Represas-Represas C, et al
    Factors Linked to Frequent Attendance in the Out-of-hospital Setting by Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:119-122.
    PubMed    
    
    
    January 2023
69. MATABUENA M, Salgado FJ, Nieto-Fontarigo JJ, Alvarez-Puebla MJ, et al
    Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis.
    Arch Bronconeumol. 2023 Jan 18:S0300-2896(23)00012.
    PubMed     Abstract available
    
    
    
70. ALIBERTI S, Gramegna A, Seia M, Malvestiti F, et al
    Alpha(1)-Antitrypsin Inherited Variants in Patients With Bronchiectasis.
    Arch Bronconeumol. 2023 Jan 18:S0300-2896(23)00009.
    PubMed    
    
    
    
71. LUJAN M
    Home High-Flow Oxygen Therapy Should Be Considered in Patients With COPD and Chronic Respiratory Failure.
    Arch Bronconeumol. 2023;59:5-6.
    PubMed    
    
    
    
72. PALONES E, Curto E, Pelegri A, Arilla M, et al
    Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia.
    Arch Bronconeumol. 2023;59:63-65.
    PubMed    
    
    
    
73. SCICLUNA V, Han M
    COPD in Women: Future Challenges.
    Arch Bronconeumol. 2023;59:3-4.
    PubMed    
    
    
    
74. AMADO DIAGO CA, Figueira Goncalves JM, Golpe R, Esteban C, et al
    Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria.
    Arch Bronconeumol. 2023;59:57-58.
    PubMed    
    
    
    December 2022
75. NIGRO M, Simonetta E, Martinez-Garcia MA, Aliberti S, et al
    Biologics in Bronchiectasis: A Future Treatment?
    Arch Bronconeumol. 2022 Dec 23:S0300-2896(22)00671.
    PubMed    
    
    
    
76. ZHAO N, Suissa S, Ernst P
    Beta-agonist Use and Increased Asthma Mortality: Reality or Fiction?
    Arch Bronconeumol. 2022 Dec 23:S0300-2896(22)00669.
    PubMed    
    
    
    
77. PIOCH CO, Connell DW, Shoemark A
    Primary Ciliary Dyskinesia and Bronchiectasis: New Data and Future Challenges.
    Arch Bronconeumol. 2022 Dec 18:S0300-2896(22)00663.
    PubMed    
    
    
    
78. GALERA R, Mergelina C, Casitas R, Martinez-Ceron E, et al
    Increased Blood Eosinophil Count Is Related to Less Daily Physical Activity in Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2022;58:837-839.
    PubMed    
    
    
    
79. LIANG Y, Sun Y
    COPD in China: Current Status and Challenges.
    Arch Bronconeumol. 2022;58:790-791.
    PubMed    
    
    
    November 2022
80. CHANG AB, Kantar A, Redding GJ, Hill AT, et al
    Is Bronchiectasis a Reversible Disorder?
    Arch Bronconeumol. 2022 Nov 19:S0300-2896(22)00633.
    PubMed    
    
    
    
81. MADRID CARBAJAL C, Palomo B, Garcia Clemente M
    Radiological Changes After Treatment With Triple Therapy in Cystic Fibrosis. Are Bronchiectasis Irreversible?
    Arch Bronconeumol. 2022 Nov 5:S0300-2896(22)00599.
    PubMed    
    
    
    
82. CALLE RUBIO M, Lopez-Campos JL, Izquierdo Alonso JL, Martinez Pitarch D, et al
    Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group.
    Arch Bronconeumol. 2022;58:776-779.
    PubMed    
    
    
    
83. ROMERO-FALCON MA, Medina-Gallardo JF, Lopez-Campos JL, Maestre Sanchez MV, et al
    Evaluation of the Diagnostic Accuracy of Non-Specific Bronchial Provocation Tests in the Diagnosis of Asthma: A Randomized Cross-Over Study.
    Arch Bronconeumol. 2022 Nov 1. pii: S0300-2896(22)00596.
    PubMed     Abstract available
    
    
    October 2022
84. FIGUEIRA-GONCALVES JM, Golpe R
    Medium- and Long-Term Consequences of SARS-CoV-2 Infection on COPD Patients.
    Arch Bronconeumol. 2022;58:729-730.
    PubMed    
    
    
    
85. MONTEAGUDO M, Nunez A, Barrecheguren M, Miravitlles M, et al
    Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study.
    Arch Bronconeumol. 2022;58:699-707.
    PubMed     Abstract available
    
    
    
86. MARTIN-ONTIYUELO C, Rodo-Pin A, Echeverria-Esnal D, Admetllo M, et al
    Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial.
    Arch Bronconeumol. 2022;58:689-698.
    PubMed     Abstract available
    
    
    September 2022
87. ALVAREZ-GUTIERREZ FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, et al
    What's New in the 2022 Consensus for Severe Asthma in Adults.
    Arch Bronconeumol. 2022 Sep 28. pii: S0300-2896(22)00575.
    PubMed    
    
    
    
88. DIAB CACERES L, Morales Ruiz R, Villena Garrido V
    Does Bronchiectasis Cause Irreversible Damage?
    Arch Bronconeumol. 2022 Sep 27. pii: S0300-2896(22)00576.
    PubMed    
    
    
    
89. SOLARAT B, Perea L, Faner R, de La Rosa D, et al
    Pathophysiology of Chronic Bronchial Infection in Bronchiectasis.
    Arch Bronconeumol. 2022 Sep 15. pii: S0300-2896(22)00525.
    PubMed     Abstract available
    
    
    
90. SADATSAFAVI M, Aaron SD, Gershon AS, Puhan M, et al
    The Hidden and Unchecked Judgement Calls When Using Exacerbation History for Managing COPD.
    Arch Bronconeumol. 2022;58:629-631.
    PubMed    
    
    
    
91. GONZALEZ J, Carmona P, Gracia-Lavedan E, Benitez ID, et al
    Cluster Analysis of Home Mechanical Ventilation in COPD Patients: A Picture of the Real World and Its Impact on Mortality.
    Arch Bronconeumol. 2022;58:642-648.
    PubMed     Abstract available
    
    
    
92. RODRIGO-TROYANO A, Giner J, Perea L, Merino JL, et al
    Predicting Early Hospital Readmissions in COPD Patients Using an Electronic Nose.
    Arch Bronconeumol. 2022;58:663-665.
    PubMed    
    
    
    August 2022
93. COSIO BG, Shafiek H, Martinez-Garcia MA
    Is it Time to Readjust the Doses of Inhaled Corticosteroids in COPD?
    Arch Bronconeumol. 2022;58:593-594.
    PubMed    
    
    
    
94. ALCAZAR-NAVARRETE B, Diaz-Lopez JM, Garcia-Flores P, Ortega-Antelo M, et al
    T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2022;58:595-600.
    PubMed     Abstract available
    
    
    
95. SU KC, Ko HK, Hsiao YH, Chou KT, et al
    Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial.
    Arch Bronconeumol. 2022;58:601-610.
    PubMed     Abstract available
    
    
    
96. SORIANO JB, Dai X, Ancochea J
    An Euler Proportional Venn Diagram of Obstructive Lung Disease.
    Arch Bronconeumol. 2022;58:627-628.
    PubMed    
    
    
    July 2022
97. KUNADHARAJU R, Rudraraju A, Sethi S
    Pseudomonas aeruginosa Colonization and COPD: The Chicken or the Egg?
    Arch Bronconeumol. 2022;58:539-541.
    PubMed    
    
    
    June 2022
98. XU JF, Gao YH, Guan WJ
    Advances in Bronchiectasis Registries: The New Chinese Registry.
    Arch Bronconeumol. 2022 Jun 11. pii: S0300-2896(22)00447.
    PubMed    
    
    
    
99. KATSOULIS K, Kipourou M, Quaranta Vitaliano N, Kostikas K, et al
    Predicting Bronchial Hyperresponsiveness in Patients with Asthma: The Role of Impulse Oscillometry.
    Arch Bronconeumol. 2022 Jun 2. pii: S0300-2896(22)00438.
    PubMed    
    
    
    
100. LONG MB, Chalmers JD
     Treating Neutrophilic Inflammation in Airways Diseases.
     Arch Bronconeumol. 2022;58:463-465.
     PubMed    
     
     
     
101. MANISCALCO M, Fuschillo S, Ambrosino P, D'Anna SE, et al
     Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients.
     Arch Bronconeumol. 2022;58:517-519.
     PubMed    
     
     
     
102. LUIS IZQUIERDO J, Casanova C, Celli B, Santos S, et al
     The 7 Cardinal Sins of COPD in Spain.
     Arch Bronconeumol. 2022;58:498-503.
     PubMed     Abstract available
     
     
     
103. GARCIA-VALERO J, Olloquequi J, Rodriguez E, Martin-Satue M, et al
     Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.
     Arch Bronconeumol. 2022;58:482-489.
     PubMed     Abstract available
     
     
     
104. MARCOS PJ, Represas Represas C, Ramos C, Cimadevila Alvarez B, et al
     Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis.
     Arch Bronconeumol. 2022;58:474-481.
     PubMed     Abstract available
     
     
     May 2022
105. PASCUAL S, Dorado S, Urrutia I
     Physical Activity and Asthma.
     Arch Bronconeumol. 2022 May 17. pii: S0300-2896(22)00342.
     PubMed    
     
     
     
106. SCIOSCIA G, Alcaraz-Serrano V, Mendez R, Gabarrus A, et al
     Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
     Arch Bronconeumol. 2022 May 13. pii: S0300-2896(22)00336.
     PubMed    
     
     
     
107. MARTINEZ-GONZALEZ C, Garcia JA, Blanco I
     [Translated article] Term Pregnancy in a Patient With Severe Pulmonary Emphysema Associated With Pi*ZZ Alpha-1 Antitrypsin Deficiency.
     Arch Bronconeumol. 2022 May 5. pii: S0300-2896(22)00311.
     PubMed    
     
     
     
108. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
     [Translated article] Asthma Also Exists in Older People.
     Arch Bronconeumol. 2022 May 4. pii: S0300-2896(22)00312.
     PubMed    
     
     
     
109. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
     [Translated article] Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
     Arch Bronconeumol. 2022;58:T451-T453.
     PubMed    
     
     
     
110. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
     Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
     Arch Bronconeumol. 2022;58:412-417.
     PubMed     Abstract available
     
     
     
111. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
     [Translated article] Placental Transmogrification of the Lung.
     Arch Bronconeumol. 2022;58:T433.
     PubMed    
     
     
     
112. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
     [Translated article] Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
     Arch Bronconeumol. 2022;58:T412-T417.
     PubMed     Abstract available
     
     
     
113. PEREZ PEREZ JL, Garcia-Manso IG, Garcia Sevila R
     [Translated article] Acute Fibrinous and Organizing Pneumonia Associated With Immunotherapy (Pembrolizumab).
     Arch Bronconeumol. 2022;58:T425-T426.
     PubMed    
     
     
     
114. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
     [Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
     Arch Bronconeumol. 2022;58:T386-T387.
     PubMed    
     
     
     
115. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
     [Translated article] Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
     Arch Bronconeumol. 2022;58:T454-T456.
     PubMed    
     
     
     
116. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
     FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
     Arch Bronconeumol. 2022;58:442-443.
     PubMed    
     
     
     
117. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
     Placental Transmogrification of the Lung.
     Arch Bronconeumol. 2022;58:433.
     PubMed    
     
     
     
118. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
     With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
     Arch Bronconeumol. 2022;58:386-387.
     PubMed    
     
     
     
119. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
     [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
     Arch Bronconeumol. 2022;58:T442-T443.
     PubMed    
     
     
     
120. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
     Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
     Arch Bronconeumol. 2022;58:454-456.
     PubMed    
     
     
     
121. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
     Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
     Arch Bronconeumol. 2022;58:451-453.
     PubMed    
     
     
     April 2022
122. NAVAS-BUENO B, Casas-Maldonado F, Padilla-Galo A, Gonzalez-Moya-Mondelo E, et al
     High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study.
     Arch Bronconeumol. 2022 Apr 27. pii: S0300-2896(22)00320.
     PubMed    
     
     
     
123. CHINER-VIVES E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, et al
     Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
     Arch Bronconeumol. 2022;58 Suppl 1:39-50.
     PubMed     Abstract available
     
     
     
124. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
     [Translated article] The ANTES Program in COPD: First Year.
     Arch Bronconeumol. 2022;58:T291-T294.
     PubMed    
     
     
     
125. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
     [Translated article] Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria With GOLD 2021?
     Arch Bronconeumol. 2022;58:T364-T366.
     PubMed    
     
     
     
126. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
     Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
     Arch Bronconeumol. 2022;58:334-344.
     PubMed     Abstract available
     
     
     
127. MACHUCA AGUADO J, Sabariego-Arenas I, Idoate MA
     A Pulmonary Inflammatory Chondroid Hamartoma With So-called Placental Transmogrification Feature in a Pleural Location. Pathogenic Considerations About This Unusual Disorder.
     Arch Bronconeumol. 2022;58:363.
     PubMed    
     
     
     
128. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
     Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?
     Arch Bronconeumol. 2022;58:364-366.
     PubMed    
     
     
     
129. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
     Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
     Arch Bronconeumol. 2022;58:345-351.
     PubMed     Abstract available
     
     
     
130. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
     The ANTES program in COPD: First year.
     Arch Bronconeumol. 2022;58:291-294.
     PubMed    
     
     
     
131. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
     [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
     Arch Bronconeumol. 2022;58:T345-T351.
     PubMed     Abstract available
     
     
     
132. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
     [Translated article] Biological Biomarkers in Respiratory Diseases.
     Arch Bronconeumol. 2022;58:T323-T333.
     PubMed     Abstract available
     
     
     
133. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
     Biological Biomarkers in Respiratory Diseases.
     Arch Bronconeumol. 2022;58:323-333.
     PubMed     Abstract available
     
     
     
134. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
     [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
     Arch Bronconeumol. 2022;58:T334-T344.
     PubMed     Abstract available
     
     
     March 2022
135. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
     Asthma also exists in older people.
     Arch Bronconeumol. 2022 Mar 11. pii: S0300-2896(22)00183.
     PubMed    
     
     
     February 2022
136. MARTINEZ-GONZALEZ C, Adanez Garcia J, Blanco I
     Term pregnancy of a patient with severe pulmonary emphysema associated with (PI*ZZ) alpha-1 antitrypsin.
     Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00094.
     PubMed    
     
     
     
137. BARALDI F, Alfano F, Contoli M, Papi A, et al
     Small Airway Disease in Asthma: Why is it so Important?
     Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00093.
     PubMed    
     
     
     
138. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
     [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
     Arch Bronconeumol. 2022;58:T150-T158.
     PubMed     Abstract available
     
     
     
139. CAZZOLA M, Rogliani P, Matera MG
     The Future of Bronchodilators in COPD and Asthma.
     Arch Bronconeumol. 2022;58:107-108.
     PubMed    
     
     
     
140. SOLER-CATALUNA JJ, Pinera P, Trigueros JA, Calle M, et al
     [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome.
     Arch Bronconeumol. 2022;58:T159-T170.
     PubMed     Abstract available
     
     
     
141. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
     [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
     Arch Bronconeumol. 2022;58:T150-T158.
     PubMed     Abstract available
     
     
     January 2022
142. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
     Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
     Arch Bronconeumol. 2022;58:35-51.
     PubMed     Abstract available
     
     
     December 2021
143. MARTINEZ-GARCIA MA, Aksamit TR, Aliberti S
     Bronchiectasis as a Long-Term Consequence of SARS-COVID-19 Pneumonia: Future Studies are Needed.
     Arch Bronconeumol. 2021;57:739-740.
     PubMed    
     
     
     
144. FIGUEIRA GONCALVES JM, Golpe R, Ramallo Y, Garcia Talavera I, et al
     Should pulse oximeter saturations be included in the risk stratification for chronic obstructive pulmonary disease proposed by GesEPOC?
     Arch Bronconeumol. 2021;57:774-776.
     PubMed    
     
     
     
145. CALLE RUBIO M, Rodriguez Hermosa JL, Miravitlles M, Lopez-Campos JL, et al
     Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study.
     Arch Bronconeumol. 2021;57:741-749.
     PubMed     Abstract available
     
     
     
146. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
     Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
     Arch Bronconeumol. 2021;57:731-732.
     PubMed    
     
     
     November 2021
147. OJANGUREN I, Satia I, Usmani OS
     The Role of Viral Infections on Severe Asthma Exacerbations: Present and Future.
     Arch Bronconeumol. 2021 Nov 1. pii: S0300-2896(21)00350.
     PubMed    
     
     
     
148. LOPEZ-ALBA A, Aldao-Arguelles I, de Granda-Orive JI
     Plastic bronchitis and Noonan syndrome.
     Arch Bronconeumol. 2021;57:705.
     PubMed    
     
     
     
149. FERREIRO A, Granados G, Villar A
     Peribronchovascular emphysema. The Macklin effect.
     Arch Bronconeumol. 2021;57:697.
     PubMed    
     
     
     
150. DE-TORRES JP, Wisnivesky JP
     Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
     Arch Bronconeumol. 2021;57:679-680.
     PubMed    
     
     
     
151. MARTINEZ-GARCIA MA
     Bronchiectasis and Eosinophils.
     Arch Bronconeumol. 2021;57:671-672.
     PubMed    
     
     
     October 2021
152. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
     Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis.
     Arch Bronconeumol. 2021;57:662-664.
     PubMed    
     
     
     
153. RUANO-RAVINA A, Cameselle-Lago C, Torres-Duran M, Pando-Sandoval A, et al
     Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.
     Arch Bronconeumol. 2021;57:630-636.
     PubMed     Abstract available
     
     
     
154. SUEHS CM, Bourdin A
     Tapering of Oral Corticosteroids for the Treatment of Asthma.
     Arch Bronconeumol. 2021;57:621-622.
     PubMed    
     
     
     
155. COHEN M, Casas A, Zabert G, Torres-Duque CA, et al
     Updated Strategic Plan of the Latin American Thoracic Association (ALAT). "The ten commandments for 2021-2026 quinquennial".
     Arch Bronconeumol. 2021;57:617-620.
     PubMed    
     
     
     
156. MARTINEZ-VERGARA A, Giron RM, Churruca-Arrospide M, Lopez-Pereira P, et al
     Clinical course of patients with bronchiolitis obliterans following hematopoietic stem cell transplantation.
     Arch Bronconeumol. 2021;57:664-666.
     PubMed    
     
     
     September 2021
157. ALCARAZ-SERRANO V, Lee AL, Gimeno-Santos E
     Respiratory Physiotherapy and Bronchiectasis.
     Arch Bronconeumol. 2021 Sep 14. pii: S0300-2896(21)00316.
     PubMed    
     
     
     
158. BLANCO-CONDE S, Gonzalez-Cortes C, Lopez-Medrano R, Carazo-Fernandez L, et al
     Mycobacterium abscessus Infected Neutrophils as an In Vitro Model for Bronchiectasis. Neutrophils Prevent Mycobacterial Aggregation.
     Arch Bronconeumol. 2021 Sep 4. pii: S0300-2896(21)00231.
     PubMed    
     
     
     
159. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
     Vitamin D supplementation: A treatment with possible benefits in asthma.
     Arch Bronconeumol. 2021;57:567-568.
     PubMed    
     
     
     
160. GOLPE R, Dacal-Rivas D, Blanco-Cid N, Castro-Anon O, et al
     Need for Epidemiological Studies on Chronic Obstructive Pulmonary Disease in Rural Spain.
     Arch Bronconeumol. 2021;57:614-615.
     PubMed    
     
     
     
161. CARRASCO HERNANDEZ L, Caballero Eraso C, Abad Arranz M, Marquez Martin E, et al
     Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow.
     Arch Bronconeumol. 2021;57:593-594.
     PubMed    
     
     
     
162. COSIO BG, Shafiek H, Verdu J, Fiorentino F, et al
     Implementation of an Integrated Care Model for Frequent-Exacerbator COPD Patients: A Controlled Prospective Study.
     Arch Bronconeumol. 2021;57:577-583.
     PubMed     Abstract available
     
     
     
163. ALONSO-PEREZ T, Garcia-Castillo E, Lopez-Campos JL
     Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?
     Arch Bronconeumol. 2021;57:604-605.
     PubMed    
     
     
     
164. LOPEZ-CAMPOS JL, Calle Rubio M, Izquierdo Alonso JL, Fernandez-Villar A, et al
     Forum COPD working group consensus on the diagnosis, treatment and follow-up of COPD.
     Arch Bronconeumol. 2021;57:596-599.
     PubMed    
     
     
     August 2021
165. EZPONDA A, Casanova C, Cabrera C, Martin-Palmero A, et al
     Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients.
     Arch Bronconeumol. 2021;57:533-539.
     PubMed     Abstract available
     
     
     
166. MOROLI RG, Santos DOD, Souza HCD, Perossi L, et al
     Effects of Controlled Voluntary Increase in the Ventilatory Demand on Respiratory System Resistance in Healthy and Non-Cystic Fibrosis Bronchiectasis Subjects: A Cross-Sectional Study.
     Arch Bronconeumol. 2021;57:528-532.
     PubMed     Abstract available
     
     
     
167. GARCIA-SANZ MT, Gonzalez-Barcala FJ
     COPD is more than just lung function: Let's not forget depression.
     Arch Bronconeumol. 2021;57:519-520.
     PubMed    
     
     
     July 2021
168. MCDONALD VM, Gibson PG
     Treatable Traits in Asthma and COPD.
     Arch Bronconeumol. 2021 Jul 16. pii: S0300-2896(21)00206.
     PubMed    
     
     
     
169. LOPEZ-VILLARRUBIA E, Costa Estirado O, Iniguez Hernandez C, Ballester Diez F, et al
     Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?
     Arch Bronconeumol. 2021;57:464-470.
     PubMed     Abstract available
     
     
     June 2021
170. MARCHIORI E, Souza Rodrigues R, Menna Barreto M
     Exuberant Paraseptal Emphysema Associated With Pulmonary Alveolar Microlithiasis: 12 Years of Evolution.
     Arch Bronconeumol. 2021 Jun 24. pii: S0300-2896(21)00196.
     PubMed    
     
     
     April 2021
171. SAWAMURA MVY, Athanazio RA, Nucci MCNTM, Rached SZ, et al
     Automated Computed Tomography Lung Densitometry in Bronchiectasis Patients.
     Arch Bronconeumol. 2021 Apr 25. pii: S0300-2896(21)00136.
     PubMed    
     
     
     January 2021
172. ALMONACID C, Blanco-Aparicio M, Dominguez-Ortega J, Giner J, et al
     [Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19].
     Arch Bronconeumol. 2021;57:13-14.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.